DOCSLIB.ORG

Printmgr File

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Printmgr File 707448 Edison_Fancy Cover Eng_HR.pdf 1 22/4/2019 10:53:00 AM (Incorporated in the Cayman Islands as an exempted company with limited liability) Sole Sponsor Joint Global Coordinators, Joint Bookrunners, Joint Lead Managers Joint Bookrunners, Joint Lead Managers Joint Lead Managers IMPORTANT IMPORTANT: If you are in any doubt about any of the contents of this prospectus, you should obtain independent professional advice. VIVA BIOTECH HOLDINGS (Incorporated in the Cayman Islands as an exempted company with limited liability) GLOBAL OFFERING Number of Offer Shares under the Global Offering : 345,000,000 Shares (subject to the Over-allotment Option) Number of Hong Kong Offer Shares : 34,500,000 Shares (subject to reallocation) Number of International Offer Shares : 310,500,000 Shares (subject to reallocation and the Over- allotment Option) Maximum Offer Price : HK$4.41 per Offer Share, plus brokerage of 1%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) Nominal value : US$0.000025 per Share Stock code : 1873 Sole Sponsor Joint Global Coordinators, Joint Bookrunners, Joint Lead Managers Joint Bookrunners, Joint Lead Managers Joint Lead Managers Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this prospectus, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this prospectus. A copy of this prospectus, having attached thereto the documents specified in “Appendix V — Documents Delivered to the Registrar of Companies and Available for Inspection”, has been registered by the Registrar of Companies in Hong Kong as required by section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). The Securities and Futures Commission and the Registrar of Companies in Hong Kong take no responsibility for the contents of this prospectus or any other document referred to above. The Offer Price is expected to be determined by agreement between the Joint Representatives and our Company on or about Tuesday, April 30, 2019 and, in any event, not later than Wednesday, May 8, 2019. The Offer Price will be not more than HK$4.41 per Offer Share and is currently expected to be not less than HK$3.42 per Offer Share, unless otherwise announced. Investors applying for the Hong Kong Offer Shares must pay, on application, the maximum Offer Price of HK$4.41 per Offer Share, together with brokerage of 1.0%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005%, subject to refund if the Offer Price is less than HK$4.41 per Offer Share. The Joint Representatives, with our consent, may reduce the number of Offer Shares being offered under the Global Offering and/or the Offer Price stated in this prospectus at any time on or prior to the morning of the last day for lodging applications under the Hong Kong Public Offering. In such a case, an announcement will be published in the South China Morning Post (in English) and the Hong Kong Economic Times (in Chinese) and on the websites of the Stock Exchange at www.hkexnews.hk and our Company at www.vivabiotech.com not later than the morning of the day which is the last day for lodging applications under the Hong Kong Public Offering. Details of the arrangement will then be announced by us as soon as practicable. For further information, please see the sections headed “Structure of the Global Offering” and “How to Apply for Hong Kong Offer Shares”. The obligations of the Hong Kong Underwriters under the Hong Kong Underwriting Agreement are subject to termination by the Joint Representatives if certain grounds arise prior to 8:00 a.m. on the Listing Date. Please see the section headed “Underwriting — Underwriting Arrangements and Expenses — The Hong Kong Public Offering — Grounds for Termination.” The Shares have not been and will not be registered under the U.S. Securities Act or any state securities law of the United States. The Company has not been and will not be registered under the U.S. Investment Company Act, in reliance on the exemption provided by Section 3(c)(7) thereof. The Offer Shares may not be offered, sold, pledged or transferred within the United States, except that Offer Shares may be offered, sold or delivered to persons who are both (i) QIBs and (ii) Qualified Purchasers, in reliance on an exemption from registration under the U.S. Securities Act provided by, and in accordance with the restrictions of, Rule 144A or another exemption from the registration requirements of the U.S. Securities Act. The Offer Shares may be offered, sold or delivered outside of the United States to persons who are neither (i) U.S. Persons (as defined in Regulation S including also any person that is not a U.S. person solely by reason of Rule 902(k)(1)(viii)(B) or 902(k)(2)(i) under Regulation S) nor (ii) U.S. residents (as defined for purposes of the U.S. Investment Company Act) in offshore transactions in accordance with Regulation S. Each person acquiring any Offer Shares in making such acquisition will be deemed to have made certain acknowledgments, representations and agreements as set forth in the section headed “Information About this Prospectus and the Global Offering — Restrictions on Offer and Sale of the Offer Shares” of this prospectus. April 25, 2019 EXPECTED TIMETABLE(1) If there is any change in the following expected timetable of the Hong Kong Public Offering, we will issue an announcement in Hong Kong to be published in English in the South China Morning Post and in Chinese in the Hong Kong Economic Times. Latest time to complete electronic applications under HK eIPO White Form service through the designated website www.hkeipo.hk(2) .......................... 11:30 a.m. on Tuesday, April 30, 2019 Application lists of the Hong Kong Public Offering open(3) . 11:45 a.m. on Tuesday, April 30, 2019 Latest time to lodge WHITE and YELLOW Application Forms ........................................... 12:00 noon on Tuesday, April 30, 2019 Latest time to give electronic application instructions to HKSCC(4) ........................................ 12:00 noon on Tuesday, April 30, 2019 Latest time to complete payment of HK eIPO White Form applications by effecting internet banking transfer(s) or PPS payment transfer(s) ................................ 12:00 noon on Tuesday, April 30, 2019 Application lists of the Hong Kong Public Offering close .... 12:00 noon on Tuesday, April 30, 2019 Expected Price Determination Date ..................... Tuesday, April 30, 2019 (1) Announcement of: Š the level of applications in the Hong Kong Public Offering; Š the indication of level of interest in the International Offering; and Š the basis of allocation of the Hong Kong Offer Shares expected to be published in the South China Morning Post (in English) and the Hong Kong Economic Times (in Chinese) and on the websites of the Stock Exchange at www.hkexnews.hk and our Company at www.vivabiotech.com on or before ................. Wednesday, May 8, 2019 (2) Announcement of results of allocations in the Hong Kong Public Offering (including successful applicants’ identification document numbers, where appropriate) to be available through a variety of channels including the website of the Stock Exchange at www.hkexnews.hk and our Company’s website at www.vivabiotech.com (see the section headed “How to Apply for Hong Kong Offer Shares — 11. Publication of Results”) from ...... Wednesday, May 8, 2019 (3) A full announcement of the Hong Kong Public Offering containing (1) and (2) above to be published on the website of the Stock Exchange at www.hkexnews.hk(5) and our Company’s website at www.vivabiotech.com(6) from .......................................... Wednesday, May 8, 2019 Results of allocations in the Hong Kong Public Offering (with successful applicants’ identification document numbers where appropriate) will be available at www.tricor.com.hk/ipo/result (or www.hkeipo.hk/ IPOResult) with a “search by ID” function from ........ Wednesday, May 8, 2019 Dispatch/collection of share certificates in respect of wholly or partially successful applications pursuant to the Hong Kong Public Offering on or before(7) .................. Wednesday, May 8, 2019 i EXPECTED TIMETABLE(1) Dispatch/collection of HK eIPO White Form e-Auto Refund payment instructions/refund cheques in respect of wholly or partially successful applications on or before(8)(9) ......... Wednesday, May 8, 2019 Dealings in Shares on the Stock Exchange expected to commence on ..................................... Thursday, May 9, 2019 Notes: (1) All times and dates refer to Hong Kong local time and date, except as otherwise stated. (2) You will not be permitted to submit your application through the designated website at www.hkeipo.hk after 11:30 a.m. on the last day for submitting applications. If you have already submitted your application and obtained an application reference number from the designated website prior to 11:30 a.m., you will be permitted to continue the application process (by completing payment of application monies) until 12:00 noon on the last day for submitting applications, when the application lists close. (3) If there is a tropical cyclone warning signal number 8 or above, or a “black” rainstorm warning in force in Hong Kong at any time between 9:00 a.m. and 12:00 noon on Tuesday, April 30, 2019, the application lists will not open on that day. Please see the section headed “How to Apply for Hong Kong Offer Shares — 10.
Load more

Recommended publications
  • Shanghai, China Overview Introduction
    Shanghai, China Overview Introduction The name Shanghai still conjures images of romance, mystery and adventure, but for decades it was an austere backwater. After the success of Mao Zedong's communist revolution in 1949, the authorities clamped down hard on Shanghai, castigating China's second city for its prewar status as a playground of gangsters and colonial adventurers. And so it was. In its heyday, the 1920s and '30s, cosmopolitan Shanghai was a dynamic melting pot for people, ideas and money from all over the planet. Business boomed, fortunes were made, and everything seemed possible. It was a time of breakneck industrial progress, swaggering confidence and smoky jazz venues. Thanks to economic reforms implemented in the 1980s by Deng Xiaoping, Shanghai's commercial potential has reemerged and is flourishing again. Stand today on the historic Bund and look across the Huangpu River. The soaring 1,614-ft/492-m Shanghai World Financial Center tower looms over the ambitious skyline of the Pudong financial district. Alongside it are other key landmarks: the glittering, 88- story Jinmao Building; the rocket-shaped Oriental Pearl TV Tower; and the Shanghai Stock Exchange. The 128-story Shanghai Tower is the tallest building in China (and, after the Burj Khalifa in Dubai, the second-tallest in the world). Glass-and-steel skyscrapers reach for the clouds, Mercedes sedans cruise the neon-lit streets, luxury- brand boutiques stock all the stylish trappings available in New York, and the restaurant, bar and clubbing scene pulsates with an energy all its own. Perhaps more than any other city in Asia, Shanghai has the confidence and sheer determination to forge a glittering future as one of the world's most important commercial centers.
    [Show full text]
  • Kangji Medical Holdings Limited 康基醫療控股有限公司 (Incorporated in the Cayman Islands with Limited Liability)
    IMPORTANT IMPORTANT: If you are in any doubt about any of the contents of this prospectus, you should obtain independent professional advice. Kangji Medical Holdings Limited 康基醫療控股有限公司 (Incorporated in the Cayman Islands with limited liability) GLOBAL OFFERING Number of Offer Shares under : 225,397,500 Shares (subject to the Over- the Global Offering allotment Option) Number of Hong Kong Offer Shares : 22,540,000 Shares (subject to adjustment) Number of International Offer Shares : 202,857,500 Shares (subject to adjustment and the Over-allotment Option) Maximum Offer Price : HK$13.88 per Share, plus brokerage of 1.0%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong Dollars and subject to refund) Par Value : US$0.00001 per Share Stock Code : 9997 Joint Sponsors, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this prospectus, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this prospectus. A copy of this prospectus, having attached thereto the documents specified in “Appendix V — Documents Delivered to the Registrar of Companies and Available for Inspection — Documents Delivered to the Registrar of Companies in Hong Kong,” has been registered by the Registrar of Companies in Hong Kong as required by Section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong).
    [Show full text]
  • KANGJI MEDICAL HOLDINGS LIMITED 康基醫療控股有限公司 (The “Company”) (Incorporated in the Cayman Islands with Limited Liability)
    The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of KANGJI MEDICAL HOLDINGS LIMITED 康基醫療控股有限公司 (the “Company”) (Incorporated in the Cayman Islands with limited liability) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) and the Securities and Futures Commission (the “Commission”) solely for the purpose of providing information to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to change which can be material. By viewing this document, you acknowledge, accept and agree with the Company, its joint sponsors, advisors or members of the underwriting syndicate that: (a) this document is only for the purpose of providing information about the Company to the public in Hong Kong and not for any other purposes. No investment decision should be based on the information contained in this document; (b) the publication of this document or supplemental, revised or replacement pages on the Stock Exchange’s website does not give rise to any obligation of the Company, its joint sponsors, advisors or members of the underwriting syndicate to proceed with an offering
    [Show full text]
  • Imperial Tombs of the Ming and Qing Dynasties
    WHC Nomination Documentation File Name: 1004.pdf UNESCO Region: ASIA AND THE PACIFIC __________________________________________________________________________________________________ SITE NAME: Imperial Tombs of the Ming and Qing Dynasties DA TE OF INSCRIPTION: 2nd December 2000 STATE PARTY: CHINA CRITERIA: C (i) (ii) (iii) (iv) (vi) DECISION OF THE WORLD HERITAGE COMMITTEE: Criterion (i):The harmonious integration of remarkable architectural groups in a natural environment chosen to meet the criteria of geomancy (Fengshui) makes the Ming and Qing Imperial Tombs masterpieces of human creative genius. Criteria (ii), (iii) and (iv):The imperial mausolea are outstanding testimony to a cultural and architectural tradition that for over five hundred years dominated this part of the world; by reason of their integration into the natural environment, they make up a unique ensemble of cultural landscapes. Criterion (vi):The Ming and Qing Tombs are dazzling illustrations of the beliefs, world view, and geomantic theories of Fengshui prevalent in feudal China. They have served as burial edifices for illustrious personages and as the theatre for major events that have marked the history of China. The Committee took note, with appreciation, of the State Party's intention to nominate the Mingshaoling Mausoleum at Nanjing (Jiangsu Province) and the Changping complex in the future as an extention to the Imperial Tombs of the Ming and Qing dynasties. BRIEF DESCRIPTIONS The Ming and Qing imperial tombs are natural sites modified by human influence, carefully chosen according to the principles of geomancy (Fengshui) to house numerous buildings of traditional architectural design and decoration. They illustrate the continuity over five centuries of a world view and concept of power specific to feudal China.
    [Show full text]
  • For Personal Use Only 603 Page 1/3 15 July 2001
    For personal use only 603 page 1/3 15 July 2001 Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder To Company Name/Scheme Virgin Australia Holdings Ltd ACN/ARSN 100686226 1. Details of substantial holder (1) Name HNA Tourism Group Co., Ltd (海航旅业集团有限公司) and each of the other entities set out at Annexure A. ACN/ARSN (if applicable) This notice is given by HNA Tourism Group Co., Ltd (海航旅业集团有限公司)on behalf of itself and each of the other entities named in the list of 1 pages annexed to this notice and marked A. The holder became a substantial holder on 23/06/2016 – 14/08/2017 1 2. Details of voting power The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows: Class of Number of securities Person’s votes (5) Voting power (6) securities (4) ORD 1,676,736,791 1,676,736,791 19.82% 3. Details of relevant interests The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows: Holder of relevant interest Nature of relevant interest (7) Class and number of securities HNA Tourism (International) Investment Group Co., Ltd. acquired 60% of the issued capital of HNA Innovation Ventures (Hong Kong) Co., Limited on 14 August 2017 due to internal HNA Tourism (International) Investment restructuring (as described further at Annexure ORD 1,676,736,791 Group Co., Ltd.
    [Show full text]
  • This Article Appeared in the Beijinger's Sep-Oct Issue. Click Through To
    MID-AUTUMN FEST FOODS CAT CAFÉS BIRDING BEIJING TAIPEI 2017/09-10 EXPLORING BEIJING URBAN EXPLORATION, ALT-ACTIVITIES, AND CITY CeNTER HIKES 2017 Pizza Cup For more details, please visit thebeijinger.com or September 16 17 scan the QR code Theme:Carnival Wangjing SOHO Door: RMB 25 Presale: RMB 20 1 SEP/OCT 2017 旗下出版物 A Publication of MID-AUTUMN FEST FOODS CAT CAFÉS BIRDING BEIJING TAIPEI 2 0 1 7/ 0 9 - 1 0 出版发行: 云南出版集团 云南科技出版社有限责任公司 地址: 云南省昆明市环城西路609号, 云南新闻出版大楼2306室 责任编辑: 欧阳鹏, 张磊 书号: 978-7-900747-90-7 E XP LO R I N G BEIJING UR BAN EXPLORATION, ALT- ACTIVITI ES , A N D CI T Y CE NT ER H I K ES Since 2001 | 2001年创刊 thebeijinger.com A Publication of 广告代理: 北京爱见达广告有限公司 地址: 北京市朝阳区关东店北街核桃园30号 孚兴写字楼C座5层, 100020 Advertising Hotline/广告热线: 5941 0368, [email protected] Since 2006 | 2006年创刊 Beijing-kids.com Managing Editor Tom Arnstein Editors Kyle Mullin, Tracy Wang Copy Editor Mary Kate White Contributors Jeremiah Jenne, Andrew Killeen, Robynne Tindall 国际教育 · 家庭生活 · 都市资讯 True Run Media Founder & CEO Michael Wester Owner & Co-Founder Toni Ma 菁 彩 成 长 ：孩 子 有 Art Director Susu Luo 认 知 障 碍 怎 么 办 ？ How Can Parents Help Kids Designer Vila Wu With Special Needs? Production Manager Joey Guo Content Marketing Manager Robynne Tindall Marketing Director Lareina Yang Events & Brand Manager Mu Yu Marketing Team Helen Liu, Cindy Zhang 封面故事 教 育 创 新 ， 未 来 可 期 Head of HR & Admin Tobal Loyola Innovative Education for the Future Finance Manager Judy Zhao Accountant Vicky Cui Since 2012 | 2012年创刊 Jingkids.com HR & Admin Officer Cao Zheng Digital Development Director
    [Show full text]
  • Are You Ready?
    Are You Ready? Dear students, it is probably the first time for most of you to leave your hometown to study in Beijing. You are likely to meet challenges from many aspects such as communication, diet, social relations, etc. Facing all the problems in this new environment, you may feel tired and stressed out. However, please do believe that the majority of the problems are solvable as long as you make every effort to find appropriate and legal solutions. In order to make a smooth transition, here is a checklist of things to do: ●Familiarize yourself with the new surroundings: get familiar with BNU campus; remember the location of the places you may frequently visit such as banks, cafeterias, International Students Office, etc; ●Master basic Chinese vocabulary for daily use as soon as possible; ●Grab every opportunity to communicate with student societies and friends in China; ●Make at least one Chinese friend; ●Find a few people who can give you support any time in various areas; ●Remember a few emergency telephone numbers; ●Note a few useful websites. If you study in China for over six months, here are a few things you can do to make your study experience in China unforgettable: 1.Make at least one Chinese good friend; 2.Learn to cook at least one Chinese dish; 3.Try to learn a Chinese art such as martial art, calligraphy, paper-cut, etc; 4.Watch a Chinese movie; 5.Watch a Chinese opera; 6.Visit a local Chinese family; 7.Experience a Chinese festival; 2 3 8.Take an excursion with Chinese friends; 9.Visit parks at the weekends; 10.Go to a karaoke bar with Chinese friends; 11.Learn some Chinese proverbs or sayings; 12.Taste all kinds of special regional foods.
    [Show full text]
  • Approved Agent List Office Agent Name Main Email Office Address Office City State/Prov Office Country Ince
    Approved Agent List Office Agent Name Main Email Office Address Office City State/Prov Office Country ince Study Care - Tirana [email protected] Abdyl Frasheri Street Tirana Albania Bridge Blue Pty Ltd - Albania [email protected] K2-No.6 Rruga Naim Frashëri Tiranë Albania MasterWise Algeria [email protected] 116 Boulevard Des Martyrs el Madania Algiers Algeria Follow Me 4 English [email protected] Cite 20 Aout 1955, N.59, Oued El Romane El Achour Algiers Algeria CW International Education [email protected] J.F. Segui 3967 Piso 6 A (1425) Buenos Aires Argentina Latino Australia Education - Buenos Aires [email protected] Riobamba 972 4-C / Capital Federal Buenos Aires Argentina Marcelo T. de Alvear 818. Ciudad de Buenos Mundo Joven Travel Shop - Buenos Aires [email protected] Buenos Aires Argentina Aires. (C1058AAL) 25 de Mayo 252 2-B Vicente Lopez Provincia de TEDUCAustralia - Buenos Aires [email protected] Buenos Aires Argentina Buenos Aires Latino Australia Education - Mendoza [email protected] R. Obligado 37 - Oficina S3 Godoy Cruz Mendoza Argentina 1st Education Australia Pty Ltd [email protected] Unit 4, Level 12, 108 King William Street Adelaide SA Australia A & A International Education - Adelaide [email protected] Suite 618, 38 Gawler Place Adelaide SA Australia Amaxgrace Pty Ltd [email protected] Level 6, 108 King William Street Adelaide SA Australia AOJI Education Australia Pty Ltd - Adelaide [email protected] Leve 1, 32-34
    [Show full text]
  • Beijing Travel Eguide
    Travel eGuides ® the world at your fingertips … Beijing, China Beijing eGuide.com Introduction Beijing, the capital of China is a vibrant, modern city with a strong culture and heritage. Beijing provides much for the visitor to experience and enjoy. For the traveller, Beijing is a welcoming city offering a wide variety options. Combining the heritage of an ancient history with the excitement of a rapidly growing metropolis, Beijing has something for every mood or interest. Fans of culture can enjoy a performance of the classic Beijing Opera, a Kung Fu show, Beijing acrobatics, or a night at one of the city's many theatres or cinemas. Those looking for nightlife will enjoy the already large and constantly growing list of Beijing restaurants and bars. From the Forbidden City to the Great Wall, Tiananmen Square to the bird's nest Olympic Stadium, there is an endless list of things to see in and around Beijing. In fact, there is so much to do that it is easy for the traveller to become overwhelmed. Fortunately, there are many opportunities to relax. Whether you sit in one of the many parks or temples, spend the afternoon over a pot of tea or indulge in a famous Beijing massage, there are just as many was to do nothing in Beijing as there are activities. Some of the main attractions are Tiananmen Square, the Forbidden City, the Great Wall, Beihai Park, the Summer Palace, the Temple of Heaven, Fragrant Hill, the Peking Man, the Big Bell Temple, the Ming Tombs, the Lugou Bridge and the Grand View Garden.
    [Show full text]
  • CSI Info Booklet.Pdf
    Preface By choosing to come to China, you have proven to be an adventurous and daring type and therefore are not afraid of exploring and experiencing unfamiliar things. The purpose of this booklet is to make your journey a little smoother and more enjoyable. This booklet consists of four parts. The first provides you with basic survival Chinese to deal with situations you may encounter in the first few days. The second familiarizes you with the Peking University campus where you will live and study for a semester. An introduction to getting around in Beijing comes in the third part. Finally, the fourth will enable you to interact with the locals more effectively and make better travel plans to other regions of the country, etc. Good luck and enjoy your China experience! www.china-studies.net Acculturation Acculturation is a process by which one’s own culture is modified as a result of contact with a different culture. It is your first task and final goal in China. We all have high hopes for you! Acculturative stress or ―culture shock‖ is something you may experience when coming to China, as its culture is so "alien" or different from what you are used to. We therefore have the following advice: Embrace the changes in your environment with a positive attitude and always be optimistic, hopeful, resilient, and confident. Find social support through friends and family and share your experience with them. Try not to spend all of your time online, but go out to local attractions and make new friends. You can always get help from our office.
    [Show full text]
  • China Provider List May 2021 for BG Member Without
    直接付费医疗机构列表 管理方 Managed by CHINA PROVIDER NETWORK LIST FOR BG MEMBER 2021年09月 Sep. 2021 通过“保险直付”，我们可以与您就诊的医疗机构进行直接联系并对您保障范围内的医疗费用进行保险直接结算。如果您在“保险直付”的网络医院或诊所就诊，只需在就诊前出示您的永诚保险卡给相关的医护人员。医院或诊所将会就保险直付事宜联系我们并确保我们支付您保障范围内的治疗费用。如果您有任何问题可以随时拨打我们的7天24小时服务热线。 如您选择在公立医院就诊，请务必预先电话预约以确保您能按时得到预约专家的诊疗及直接付费服务。由于保险计划不同, 您的部分医疗服务可能无法享受直接付费服务，请联系Bupa客服电话 4000-687-866 或 010-58541802 查询您是否可以享受直接付费服务。 标有“电话”的项目，请联系客服出具保险福利确认函。 "Direct billing" allows us to be in direct contact with your hospital or clinic so we can take care of eligible medical bills directly. To access to ‘Direct billing’ hospitals and clinics, simply show your Alltrust card to the admission staff prior to any treatment. The hospital/clinic will then contact us and we will pay them directly for the cost of eligible treatment. Please call our 24/7 helpline should you experience any difficulties. For the direct billing service in public hospitals, please make appointment in advance to make sure you will receive the treatment by the specialist successfully with direct billing service. You may not enjoy direct billing service for all medical treatment items depending on your plan design. Please contact Bupa customer service at 4000-687-866 or 010-58541802 to check whether you could enjoy direct billing service. For some item noted as "telephone", please contact customer service to get membership verification confirmation letter. 所有权 体检 医疗机构名称 医疗机构地址 联系电话 服务时间 门诊 OP 急诊 产科 儿科 中医 齿科 Owner- Health Provider Name Provider Address Telephone Service Time 住院 IP ER OB Pediatrics TCM Dental ship Screening 北京 Beijing 周一至周五：上午8:00至11:30，下午1:30至4:00 周六周日仅限急诊 010-69156699 Monday-Friday: 8:00am-11:30am, 1:30pm-4:00pm 010-69154266/5206 Saturday-Sunday: Emergency only 门诊 北京协和医院国际医疗部 （东院） 北京市东城区帅府园1号内科楼一段二层及三层 公立 (体检wellness checkup) 儿科外科不接受14岁以下儿童 OP Peking Union Medical College Hospital, 2F/3F, Session 1, Internal Medicine Building, 1# Public 010-69155288/5287 Children under 14 cannot be admmited to Pediatric Surgery 住院 International Medical Department Shuaifuyuan, Dongcheng District, Beijing ) (急诊 ER) Dept.
    [Show full text]
  • Dingdang Health Technology Group Ltd. 叮噹健康科技集團有限公司 (Incorporated in the Cayman Islands with Limited Liability)
    The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Dingdang Health Technology Group Ltd. 叮噹健康科技集團有限公司 (Incorporated in the Cayman Islands with limited liability) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) and the Securities and Futures Commission (the “Commission”) solely for the purpose of providing information to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to change which can be material. By viewing this document, you acknowledge, accept and agree with Dingdang Health Technology Group Ltd. (the “Company”, together with its subsidiaries, the “Group”), its joint sponsors, advisors or members of the underwriting syndicate that: (a) this document is only for the purpose of providing information about the Company to the public in Hong Kong and not for any other purposes. No investment decision should be based on the information contained in this document; (b) the publication of this document or any supplemental, revised or replacement pages on the Exchange’s website does not give rise to any obligation of the Company, its joint sponsors, advisors or members of the underwriting syndicate to proceed with an offering in Hong Kong or any other jurisdiction.
    [Show full text]